EUVIMEDEUVIMED entdecken
Crossref

A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?

Basem M Mishriky iD, Doyle M Cummings, James R Powell

Diabetes/Metabolism Research and Reviews · 2024

DOI: 10.1002/dmrr.3715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, 2024. Verfasst von Basem M Mishriky und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology, University of South Carolina/Prisma Health, Columbia, South Carolina, USA. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Atrial Fibrillation, Diabetes Mellitus, Type 2, Symporters. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BMM has served on Advisory Board Panels for AstraZeneca and Bayer. DMC and JRP report no conflicts of interest. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1002/dmrr.3715. The data that support the findings of this study are available from the corresponding author upon reasonable request. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsAtrial FibrillationDiabetes Mellitus, Type 2SymportersHeart FailureHumansRandomized Controlled Trials as TopicHypoglycemic AgentsGlucoseSodium

Stichwörter der Autor:innen

SGLT-2 inhibitorsatrial fibrillationcardiovascular outcome trialsheart failure trialsrenal outcome trials

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsSymportersGlucoseSodium

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Endocrinology, University of South Carolina/Prisma Health, Columbia, South Carolina, USA.
  • Department of General Internal Medicine, Duke University Health System, Raleigh, USA.
  • Department of Public Health, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
  • Department of Internal Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.

ORCID-Profile: Basem M Mishriky

Zitieren

APA

Mishriky, B. M., Cummings, D. M., & Powell, J. R. (2024). A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3715

Vancouver

Mishriky BM, Cummings DM, Powell JR. A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.3715

BibTeX
@article{Mishriky2024,
  author = {Mishriky, Basem M and Cummings, Doyle M and Powell, James R},
  title = {A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2024},
  doi = {10.1002/dmrr.3715}
}
Kostenlos starten →